Correlation Between CytomX Therapeutics and Dominari Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Dominari Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Dominari Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Dominari Holdings, you can compare the effects of market volatilities on CytomX Therapeutics and Dominari Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Dominari Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Dominari Holdings.

Diversification Opportunities for CytomX Therapeutics and Dominari Holdings

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between CytomX and Dominari is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Dominari Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dominari Holdings and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Dominari Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dominari Holdings has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Dominari Holdings go up and down completely randomly.

Pair Corralation between CytomX Therapeutics and Dominari Holdings

Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 3.72 times more return on investment than Dominari Holdings. However, CytomX Therapeutics is 3.72 times more volatile than Dominari Holdings. It trades about 0.03 of its potential returns per unit of risk. Dominari Holdings is currently generating about -0.02 per unit of risk. If you would invest  141.00  in CytomX Therapeutics on August 27, 2024 and sell it today you would lose (52.00) from holding CytomX Therapeutics or give up 36.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

CytomX Therapeutics  vs.  Dominari Holdings

 Performance 
       Timeline  
CytomX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Dominari Holdings 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating primary indicators, Dominari Holdings may actually be approaching a critical reversion point that can send shares even higher in December 2024.

CytomX Therapeutics and Dominari Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CytomX Therapeutics and Dominari Holdings

The main advantage of trading using opposite CytomX Therapeutics and Dominari Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Dominari Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dominari Holdings will offset losses from the drop in Dominari Holdings' long position.
The idea behind CytomX Therapeutics and Dominari Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences